5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.33▼ | 1.33▼ | 1.33▼ | 1.31▲ | 1.31▲ |
MA10 | 1.32▼ | 1.32▼ | 1.32▼ | 1.31▲ | 1.29▲ |
MA20 | 1.33▼ | 1.33▼ | 1.33▼ | 1.32▲ | 1.27▲ |
MA50 | 1.30▲ | 1.30▲ | 1.30▲ | 1.30▲ | 1.41▼ |
MA100 | 1.29▲ | 1.29▲ | 1.29▲ | 1.24▲ | 1.71▼ |
MA200 | 1.28▲ | 1.27▲ | 1.28▲ | 1.35▼ | 2.79▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.004▼ | -0.004▼ | -0.002▼ | 0.027▲ |
RSI | 48.319▼ | 48.856▼ | 48.933▼ | 52.659▲ | 50.769▲ |
STOCH | 40.724 | 40.724 | 40.724 | 38.875 | 64.861 |
WILL %R | -82.353▼ | -82.353▼ | -82.353▼ | -55.397 | -28.834 |
CCI | -69.613 | -69.613 | -69.613 | -35.369 | 63.205 |
Thursday, June 19, 2025 05:01 PM
The latest price target for LAVA Therapeutics (NASDAQ:LVTX) was reported by JMP Securities on May 15, 2025. The analyst firm set a price target for $0.00 expecting LVTX to fall to within 12 months ...
|
Monday, May 19, 2025 04:59 PM
LAVA Therapeutics (NASDAQ:LVTX – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for LAVA Therapeutics in a research note ...
|
Wednesday, May 14, 2025 04:55 AM
LAVA THERAPEUTICS posted quarterly earnings results on Wednesday, May 14th.The company reported earnings of -$0.13 per share, beating estimates of -$0.39 by $0.26. The company also reported ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 1.31 | 1.32 | 1.29 | 1.32 | 13,057 |
27/06/25 | 1.31 | 1.33 | 1.29 | 1.31 | 11,959 |
26/06/25 | 1.27 | 1.31 | 1.27 | 1.305 | 7,744 |
25/06/25 | 1.33 | 1.33 | 1.29 | 1.3143 | 7,181 |
24/06/25 | 1.3312 | 1.3399 | 1.29 | 1.325 | 5,899 |
23/06/25 | 1.32 | 1.34 | 1.30 | 1.325 | 4,822 |
20/06/25 | 1.35 | 1.3821 | 1.30 | 1.31 | 15,523 |
18/06/25 | 1.30 | 1.34 | 1.28 | 1.34 | 20,048 |
17/06/25 | 1.31 | 1.32 | 1.30 | 1.30 | 8,966 |
16/06/25 | 1.28 | 1.305 | 1.28 | 1.29 | 7,230 |
|
|
||||
|
|
||||
|
|